• Policy & Insight

Opinion: "There's cause for optimism in 2021 and beyond"

COVID-19 changed so much of our plans, but it didn’t change everything. In this dark year, there were still pockets of light, writes our CEO Michelle Mitchell. COVID-19 changed so much of our plans, but it didn’t change everything. In this dark year, there were still pockets of light, writes our CEO Michelle Mitchell.

30 December 2020

• Science & Technology

Scientists develop new drug that targets pathway found in several hard-to-treat cancers

After decades of no luck, scientists have finally found a way to target the KRAS mutation - a common mutation found in several hard-to-treat cancers. After decades of no luck, scientists have finally found a way to target the KRAS mutation - a common mutation found in several hard-to-treat cancers.

30 December 2020

• Charity News

Cancer research in 2020: A spotlight on Manchester

2020 has certainly been tough, and no industry has been left untouched by the effects of the pandemic. And while the same undoubtedly goes for our work, we’ve once again been inspired by the resilience and determination of our researchers. 2020 has certainly been tough, and no industry has been left untouched by the effects of the pandemic. And while the same undoubtedly goes for our work, we’ve once again been inspired by the resilience and determination of our researchers.

27 December 2020

• Science & Technology
• Policy & Insight

What could DeepMind ‘solving’ the protein folding problem mean for cancer research?

We asked two of our protein specialists, who are trying to understand how the way proteins fold affect cancer outcomes, to give their verdict on the news. We asked two of our protein specialists, who are trying to understand how the way proteins fold affect cancer outcomes, to give their verdict on the news.

23 December 2020

• For Supporters

Three influential partnerships making waves in cancer drug development

We highlight some of the most exciting science to emerge from our commercial partnerships over the past year. We highlight some of the most exciting science to emerge from our commercial partnerships over the past year.

22 December 2020

• Science & Technology
• Health & Medicine

2020 round-up: Our biggest cancer stories of the year

We've rounded-up some of the most talked about topics from the blog this year We've rounded-up some of the most talked about topics from the blog this year

20 December 2020

• Personal Stories

Coronavirus reports – Part 8: “Going into hospital was an extra layer of stress and anxiety”

We caught up with 4 people with cancer during the pandemic in part 8 of our Coronvirus reports. We caught up with 4 people with cancer during the pandemic in part 8 of our Coronvirus reports.

18 December 2020

• Health & Medicine

86% of Teens Exposed to Junk Food Ads on Social Media

Young people are being exposed to junk food adverts across social media, streaming services and by celebrities and influencers Young people are being exposed to junk food adverts across social media, streaming services and by celebrities and influencers

18 December 2020

• For Researchers

ACED one year on: a promising first year for the early detection research alliance

One year on since we launched the International Alliance for Cancer Early Detection (ACED), we look at four recently awarded research projects. One year on since we launched the International Alliance for Cancer Early Detection (ACED), we look at four recently awarded research projects.

17 December 2020

• Health & Medicine

Queues build for GP appointments and cancer tests

GPs report struggling to meet appointment demand and increased waiting times for cancer tests. GPs report struggling to meet appointment demand and increased waiting times for cancer tests.

16 December 2020

• Health & Medicine

New treatment could spare early-stage rectal cancer patients life-altering side effects

A new and less invasive treatment developed by Cancer Research UK researchers is safer than standard major surgery for early-stage rectal cancer. A new and less invasive treatment developed by Cancer Research UK researchers is safer than standard major surgery for early-stage rectal cancer.

10 December 2020

• Health & Medicine

Scottish Medicines Consortium says yes to chemotherapy-free leukaemia treatment

The Scottish Medicines Consortium (SMC) has approved a new chemotherapy-free treatment option for some adults with untreated chronic lymphocytic leukaemia. The Scottish Medicines Consortium (SMC) has approved a new chemotherapy-free treatment option for some adults with untreated chronic lymphocytic leukaemia.

8 December 2020